Skye Bioscience Cash Flow Statement (2012-2014) | SKYE

Cash Flow Statement Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jun2014 Dec2014
Operating Activities
Net Income 55.000.00M160.000.00M-712.00-0.01M0.00M-0.01M-0.14M-2.73M
Depreciation and Depletion 791.000.00M0.00M0.00M0.00M0.00M-0.01M
Gains from Investment Securities -0.00M
Cash from Operations 55.000.00M-0.01M-0.02M-0.01M-0.01M-0.00M0.00M-0.36M-1.76M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 791.000.00M0.00M0.00M0.00M0.00M-0.01M
Change in Working Capital
Change in Receivables 0.01M-0.03M0.03M-0.00M0.01M623.00
Change in Accured Expenses 0.00M0.00M0.01M0.01M0.00M-0.00M0.00M-0.17M0.06M
Change in Taxes 0.00M588.00
Other Working Capital Changes -0.00M701.000.01M-0.00M-0.01M0.02M0.08M
Investing Activities
Capital Expenditures 0.05M0.07M0.07M-0.04M
Sales of Property, Plant and Equipment 0.02M
Change in Acquisitions & Divestments 17.000.01M0.00M0.00M0.01M
Cash from Investing Activities 652.00-0.05M-0.07M-0.07M0.04M
Financing Activities
Cash from Financing Activities 0.06M0.12M0.12M0.02M-0.00M163.000.89M1.94M
Additional items
Change in Cash 707.000.01M-0.00M0.03M0.04M0.02M-0.01M0.00M0.53M0.22M
Free Cash Flow 55.000.00M-0.06M-0.09M-0.08M-0.01M-0.00M0.00M-0.36M-1.72M
Net Cash Flow 707.000.00M-0.00M0.03M0.04M0.02M-0.01M0.00M0.53M0.22M